You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: October 31, 2024

BUPIVACAINE; MELOXICAM - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic sources for bupivacaine; meloxicam and what is the scope of patent protection?

Bupivacaine; meloxicam is the generic ingredient in one branded drug marketed by Heron Theraps Inc and is included in one NDA. There are sixteen patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Bupivacaine; meloxicam has eighty-one patent family members in twenty countries.

One supplier is listed for this compound.

Summary for BUPIVACAINE; MELOXICAM
International Patents:81
US Patents:16
Tradenames:1
Applicants:1
NDAs:1
Finished Product Suppliers / Packagers: 1
Clinical Trials: 6
DailyMed Link:BUPIVACAINE; MELOXICAM at DailyMed
DrugPatentWatch® Estimated Loss of Exclusivity (LOE) Date for BUPIVACAINE; MELOXICAM
Generic Entry Date for BUPIVACAINE; MELOXICAM*:
Constraining patent/regulatory exclusivity:
Dosage:
SOLUTION, EXTENDED RELEASE;PERIARTICULAR

*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.

Recent Clinical Trials for BUPIVACAINE; MELOXICAM

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Rothman Institute OrthopaedicsPhase 3
TriHealth Inc.Phase 3
Baptist Health South FloridaPhase 4

See all BUPIVACAINE; MELOXICAM clinical trials

Pharmacology for BUPIVACAINE; MELOXICAM

US Patents and Regulatory Information for BUPIVACAINE; MELOXICAM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Heron Theraps Inc ZYNRELEF KIT bupivacaine; meloxicam SOLUTION, EXTENDED RELEASE;PERIARTICULAR 211988-001 May 12, 2021 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Heron Theraps Inc ZYNRELEF KIT bupivacaine; meloxicam SOLUTION, EXTENDED RELEASE;PERIARTICULAR 211988-003 May 12, 2021 DISCN Yes No ⤷  Sign Up ⤷  Sign Up Y ⤷  Sign Up
Heron Theraps Inc ZYNRELEF KIT bupivacaine; meloxicam SOLUTION, EXTENDED RELEASE;PERIARTICULAR 211988-003 May 12, 2021 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Heron Theraps Inc ZYNRELEF KIT bupivacaine; meloxicam SOLUTION, EXTENDED RELEASE;PERIARTICULAR 211988-001 May 12, 2021 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Heron Theraps Inc ZYNRELEF KIT bupivacaine; meloxicam SOLUTION, EXTENDED RELEASE;PERIARTICULAR 211988-003 May 12, 2021 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Heron Theraps Inc ZYNRELEF KIT bupivacaine; meloxicam SOLUTION, EXTENDED RELEASE;PERIARTICULAR 211988-004 May 12, 2021 RX Yes Yes ⤷  Sign Up ⤷  Sign Up Y ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

EU/EMA Drug Approvals for BUPIVACAINE; MELOXICAM

Company Drugname Inn Product Number / Indication Status Generic Biosimilar Orphan Marketing Authorisation Marketing Refusal
Heron Therapeutics, B.V. Zynrelef bupivacaine, meloxicam EMEA/H/C/005205
Zynrelef is indicated for treatment of somatic postoperative pain from small- to medium-sized surgical wounds in adults (see section 5.1).
Withdrawn no no no 2020-09-24
>Company >Drugname >Inn >Product Number / Indication >Status >Generic >Biosimilar >Orphan >Marketing Authorisation >Marketing Refusal

International Patents for BUPIVACAINE; MELOXICAM

Country Patent Number Title Estimated Expiration
China 106535886 长效聚合物输送系统 (Long-acting polymeric delivery systems) ⤷  Sign Up
Japan 2020169224 ポリオルトエステルおよび非プロトン性溶媒の組成物 (POLYORTHOESTER AND COMPOSITION OF APROTIC SOLVENT) ⤷  Sign Up
Denmark 3134068 ⤷  Sign Up
Slovenia 3134068 ⤷  Sign Up
China 113908284 长效聚合物输送系统 (Long-acting polymeric delivery systems) ⤷  Sign Up
Mexico 2016013719 SISTEMAS DE SUMINISTRO POLIMERICO DE ACCION PROLONGADA. (LONG-ACTING POLYMERIC DELIVERY SYSTEMS.) ⤷  Sign Up
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.